Sonoma Pharmaceuticals
SNOA
SNOA
16 hedge funds and large institutions have $2.78M invested in Sonoma Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$18.8K | |
| 2 | +$9K | |
| 3 | +$4.53K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$4K |
| 5 |
BlackRock
New York
|
+$3.58K |
Top Sellers
| 1 | -$138K | |
| 2 | -$94K | |
| 3 | -$81K | |
| 4 |
Renaissance Technologies
New York
|
-$35.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$11.9K |